Novel mechanism by which histone deacetylase inhibitors facilitate topoisomerase IIα degradation in hepatocellular carcinoma cells
about
Current systemic treatment of hepatocellular carcinoma: A review of the literatureProtein kinase CK2 and human malignant tumorsFBXW7 expression is associated with prognosis and chemotherapeutic outcome in Chinese patients with gastric adenocarcinomaEarly transcriptional alteration of histone deacetylases in a murine model of doxorubicin-induced cardiomyopathy.Systemic treatment of hepatocellular carcinoma: Past, present and futureHDAC 1/4-mediated silencing of microRNA-200b promotes chemoresistance in human lung adenocarcinoma cells.ΔNp63/DGCR8-Dependent MicroRNAs Mediate Therapeutic Efficacy of HDAC Inhibitors in Cancer.Combined Treatment with Epigenetic, Differentiating, and Chemotherapeutic Agents Cooperatively Targets Tumor-Initiating Cells in Triple-Negative Breast Cancer.Suppression of Tumor Growth and Muscle Wasting in a Transgenic Mouse Model of Pancreatic Cancer by the Novel Histone Deacetylase Inhibitor AR-42.Systemic therapies in hepatocellular carcinoma: present and future.Role of integrin-linked kinase in regulating the protein stability of the MUC1-C oncoprotein in pancreatic cancer cells.Proteasomal inhibition potentiates drugs targeting DNA topoisomerase II.The deubiquitylase USP15 regulates topoisomerase II alpha to maintain genome integrity.
P2860
Q27026036-31EB8932-FDC5-47B8-B14A-EAE81C6C947AQ27026335-6720C20A-9D92-4C91-98D1-C234258A45CEQ33630452-E451EF42-9C2E-4274-A311-CB6B13747F5DQ33853732-B6C22ED2-8454-4342-AFA0-8734DC18B82EQ33854034-0175573F-8788-47F4-8D98-54BBCAF95606Q33917640-8297038F-8ED8-4956-A1B9-86FBE36E59BEQ36051831-70AC75BC-559B-466D-B5C0-4F5C9BFEE1FBQ36918202-CE1E04A9-2D11-4946-93E0-F3BD21DEF867Q37447349-962485F9-61D2-4244-99B4-416786E95CAEQ38150875-18A88058-F503-4D07-BD10-9A19010A2A6CQ38686618-B7F65EC5-0E36-42D6-812D-08AE5CAE64FAQ38801085-19305F1C-6DD2-464E-8987-093D2B9957DBQ50074512-1BA9CA47-5FF7-4CBE-9B3F-D0B1ADD4E9DC
P2860
Novel mechanism by which histone deacetylase inhibitors facilitate topoisomerase IIα degradation in hepatocellular carcinoma cells
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Novel mechanism by which histo ...... hepatocellular carcinoma cells
@ast
Novel mechanism by which histo ...... hepatocellular carcinoma cells
@en
Novel mechanism by which histo ...... hepatocellular carcinoma cells
@nl
type
label
Novel mechanism by which histo ...... hepatocellular carcinoma cells
@ast
Novel mechanism by which histo ...... hepatocellular carcinoma cells
@en
Novel mechanism by which histo ...... hepatocellular carcinoma cells
@nl
prefLabel
Novel mechanism by which histo ...... hepatocellular carcinoma cells
@ast
Novel mechanism by which histo ...... hepatocellular carcinoma cells
@en
Novel mechanism by which histo ...... hepatocellular carcinoma cells
@nl
P2093
P2860
P356
P1433
P1476
Novel mechanism by which histo ...... hepatocellular carcinoma cells
@en
P2093
Che-Ming Teng
Ching-Shih Chen
Chun-Han Chen
Hsiao-Ching Chuang
Mei-Chuan Chen
Samuel K Kulp
P2860
P304
P356
10.1002/HEP.23964
P407
P577
2011-01-01T00:00:00Z